Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.59 |
| ▸ | CA2 | P00918 | 5/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | BACE1 | P56817 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | POLB | P06746 | 3/20 | 0.53 |
| ▸ | ALPL | P05186 | 1/20 | 0.53 |
| ▸ | ALPI | P09923 | 1/20 | 0.53 |
| ▸ | ALPG | P10696 | 1/20 | 0.53 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.51 |
| ▸ | CA9 | Q16790 | 4/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.49 |
| ▸ | DHODH | Q02127 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6882412 | 1.00 | CA12 (0.59) | CA12CA2KDM4EBACE1MEN1 | |
| SCHEMBL5391283 | 0.90 | BACE1 (0.52) | CA12CA2KDM4EBACE1MEN1 | |
| SCHEMBL5710786 | 0.90 | BACE1 (0.52) | CA12CA2KDM4EBACE1MEN1 | |
| SCHEMBL22111172 | 0.89 | KMT2A (0.58) | CA12CA2KDM4EBACE1MEN1 | |
| SCHEMBL5728715 | 0.87 | BACE1 (0.50) | CA12CA2KDM4EBACE1MEN1 | |
| SCHEMBL22111171 | 0.86 | CA12 (0.50) | CA12CA2KDM4EBACE1MEN1 | |
| SCHEMBL14666848 | 0.83 | CA2 (0.59) | CA12CA2KDM4EBACE1AMY1A | |
| SCHEMBL30241961 | 0.83 | CA2 (0.59) | CA12CA2KDM4EBACE1AMY1A | |
| SCHEMBL8756643 | 0.83 | CA12 (0.54) | CA12CA2KDM4EBACE1MEN1 | |
| SCHEMBL8756646 | 0.83 | CA12 (0.54) | CA12CA2KDM4EBACE1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013084098-A1 | ELECTROCHEMICAL CELLS COMPRISING CHELATE LIGANDS | BASF SE (DE) | 2013-06-13 | — | — | WO | disclosed |
| US-20130149588-A1 | ELECTROCHEMICAL CELLS COMPRISING CHELATE LIGANDS | BASF SE (DE) | 2013-06-13 | — | — | US | disclosed |
| US-6794526-B2 | SALEN COMPOUNDS REACTED WITHOUT INTERMEDIATE ISOLATION WITH MAGNESIUM(II) SALT TO FORM THE MANGANESE COMPLEX | CIBA SPECIALTY CHEMICALS CORPORATION | 2004-09-21 | — | — | US | disclosed |
| US-6747102-B1 | ETHYLENICALLY UNSATURATED MONOMERS ARE POLYMERIZED BY MEANS OF A FREE RADICAL POLYMERIZATION INITIATOR IN THE PRESENCE OF ORGANOMETALLIC COMPOUNDS HAVING A CONTROLLING EFFECT. | BASF AKTIENGESELLSCHAFT (DE) | 2004-06-08 | — | — | US | disclosed |
| US-20030100763-A1 | Process for the preparation of manganese complexes of salen compounds | CIBA SPECIALTY CHEMICALS CORP. | 2003-05-29 | — | — | US | disclosed |
| EP-1299403-A1 | PROCESS FOR THE PREPARATION OF MANGANESE COMPLEXES OF SALEN COMPOUNDS | Ciba SC Holding AG (CH) | 2003-04-09 | — | — | EP | disclosed |
| WO-2002002571-A1 | PROCESS FOR THE PREPARATION OF MANGANESE COMPLEXES OF SALEN COMPOUNDS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-01-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030100763-A1 | Process for the preparation of manganese complexes of salen compounds | SMN1; SMN2, SMARCC1, SMARCC2 | CA12 1977/4885CA2 2579/4885KDM4E 309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.